Quinethazone

喹乙宗

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameQuinethazone
Drug Alias NameQuinethazonum喹乙唑酮喹噻酮Hydromox
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrases inhibitors
TargetsCarbonic anhydrases
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1963/04/10
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesB. Lederle Gmbh
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC03BA02